肌缩性侧面硬化症的早期免疫系统变化与晚期疾病进展相关
Benjamin J Murdock1, Bangyao Zhao2, Ian F Webber-Davis1
1Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA.
Med (New York, N.Y.)
|April 26, 2025
概括
免疫系统的变化与肌缩侧面硬化症 (ALS) 的进展有关. 免疫失调在临床衰退之前出现,这表明它.
科学领域:
- 神经免疫学 神经免疫学
- 运动神经元疾病 运动神经元疾病
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种致命的神经退行性疾病,没有治愈.
- 免疫系统参与ALS病原体是公认的,但其作为原因或后果的作用尚不清楚.
研究的目的:
- 为了研究ALS患者的外周免疫系统变化.
- 为了确定免疫失调是否在ALS的临床进展之前或之后.
主要方法:
- 在55名ALS和50名控制参与者的22个外周免疫标记的长度月度评估使用流细胞计.
- 使用ALS功能评级尺度修订 (ALSFRS-R) 测量临床进展.
- 滞后线性回归模拟了免疫标记物变化和随后的ALSFRS-R变化之间的关系.
主要成果:
- 与对照组相比,在ALS患者中观察到免疫标记水平,轨迹和可变性的显著变化.
- 进展较快的ALS患者表现出免疫标志物变异性降低.
- 自然杀手 (NK) 细胞数量,亚种群和表面标记物与下游ALS进展有显著的关联.
结论:
- 免疫系统的调节失调在ALS中很明显,在进展较快的病例中更为明显.
- 免疫变化发生在临床衰退之前,这表明在ALS进展中可能起因作用.
更多相关视频
08:16Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
31.5K
08:47Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016
23.5K
相关概念视频
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
Amyloid Fibrils
9.0K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.0K
Alzheimer's Disease: Overview
317
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
317
